3Q2F
Crystal Structure of the bromodomain of human BAZ2B in complex with a triazolo ligand
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | ROTATING ANODE |
| Source details | RIGAKU FR-E SUPERBRIGHT |
| Temperature [K] | 100 |
| Detector technology | IMAGE PLATE |
| Collection date | 2010-12-06 |
| Detector | RIGAKU RAXIS IV |
| Wavelength(s) | 1.542 |
| Spacegroup name | C 2 2 21 |
| Unit cell lengths | 82.310, 96.350, 57.250 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 31.290 - 2.060 |
| R-factor | 0.1964 |
| Rwork | 0.194 |
| R-free | 0.24200 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3g0l |
| RMSD bond length | 0.015 |
| RMSD bond angle | 1.596 |
| Data reduction software | MOSFLM |
| Data scaling software | SCALA (3.3.16) |
| Phasing software | PHASER (2.1.4) |
| Refinement software | REFMAC |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 62.583 | 33.417 | 2.170 |
| High resolution limit [Å] | 2.060 | 6.510 | 2.060 |
| Rmerge | 0.088 | 0.748 | |
| Rmeas | 0.096 | 0.813 | |
| Rpim | 0.038 | 0.314 | |
| Total number of observations | 3071 | 13773 | |
| Number of reflections | 14455 | ||
| <I/σ(I)> | 6.4 | 12 | 2 |
| Completeness [%] | 100.0 | 98.8 | 100 |
| Redundancy | 6.8 | 6 | 6.6 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 277 | 24% PEG 1K 20% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K |






